ATYR PHARMA INC (ATYR) Forecast, Price Target & Analyst Ratings

NASDAQ:ATYRUS0021202025

Current stock price

0.8409 USD
+0.03 (+3.76%)
At close:
0.8669 USD
+0.03 (+3.09%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ATYR PHARMA INC (ATYR).

Forecast Snapshot

Consensus Price Target

Price Target
$6.48
+ 671.11% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate

ChartMill Buy Consensus

Rating
73.75%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.48
Upside
+ 671.11%
From current price of $0.84 to mean target of $6.48, Based on 16 analyst forecasts
Low
$1.01
Median
$1.02
High
$21.00

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for ATYR. The average price target is 6.48 USD. This implies a price increase of 671.11% is expected in the next year compared to the current price of 0.8409.

Analyst Ratings & History

Current Analyst Ratings

ATYR Current Analyst RatingATYR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ATYR Historical Analyst RatingsATYR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
73.75%
ATYR was analyzed by 16 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about ATYR.
In the previous month the buy percentage consensus was at a similar level.
ATYR was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-07RBC CapitalMaintains Sector Perform -> Sector Perform
2025-09-16RBC CapitalDowngrade Outperform -> Sector Perform
2025-09-16Wells FargoDowngrade Overweight -> Equal-Weight
2025-09-15HC Wainwright & Co.Downgrade Buy -> Neutral
2025-08-22JefferiesMaintains Buy -> Buy
2025-06-20Wells FargoMaintains Overweight -> Overweight
2025-06-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-18Leerink PartnersInitiate Outperform
2025-01-06Cantor FitzgeraldInitiate Overweight
2024-12-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-29HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-04Wells FargoInitiate Overweight
2024-09-05JefferiesInitiate Buy
2024-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-14RBC CapitalReiterate Outperform -> Outperform
2024-08-01HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-22HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
12.57%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-7.37%
EPS (3 Months)
8.93%

Next Earnings Summary

ATYR is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.15 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ATYR revenue by date.ATYR revenue by date.
353K
-96.60%
235K
-33.43%
190K
-19.15%

-100.00%
10.244M59.441M
480.25%
190.28M
220.12%
356.33M
87.27%
559.52M
57.02%
722.67M
29.16%
902.48M
24.88%
EBITDA
YoY % growth
ATYR ebitda by date.ATYR ebitda by date.
-54.327M
-17.66%
-67.206M
-23.71%
-76.963M
-14.52%
-64.872M
15.71%
-67.524M
-4.09%
-51.816M
23.26%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
ATYR ebit by date.ATYR ebit by date.
-54.919M
-18.35%
-67.914M
-23.66%
-77.627M
-14.30%
-75.886M
2.24%
-57.898M
23.70%
-30.95M
46.54%
55.696M
279.96%
210.29M
277.57%
363.39M
72.80%
500.34M
37.69%
657.94M
31.50%
Operating Margin
ATYR operating margin by date.ATYR operating margin by date.
-15,557.79%-28,899.57%-40,856.32%N/A-565.19%-52.07%29.27%59.02%64.95%69.23%72.90%
EPS
YoY % growth
ATYR eps by date.ATYR eps by date.
-0.96
40.00%
-0.87
9.37%
-0.79
9.20%
-0.61
22.21%
-0.47
22.82%
-0.14
70.70%
0.62
549.54%
1.36
117.55%
3.13
130.39%
4.15
32.41%
5.28
27.43%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.15
12.57%
-0.15
30.45%
-0.16
38.91%
-0.16
-11.37%
-0.19
-30.40%
-0.12
20.00%
-0.02
87.16%
0.22
243.92%
Revenue
Q2Q % growth

-100.00%
7.65M19.125M44.931M
EBITDA
Q2Q % growth
-15.3M
1.96%
-16.014M
19.85%
-16.677M
36.46%
-16.881M
-19.45%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-15.181M
3.75%
-15.435M
24.01%
-15.745M
41.13%
-16.145M
-9.12%
-19.638M
-29.36%
-12.567M
18.58%
-1.865M
88.16%
22.45M
239.05%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ATYR Yearly Revenue VS EstimatesATYR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
ATYR Yearly EPS VS EstimatesATYR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -50 -100 -150

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.18%
EPS Next 5 Year
30.05%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
745.98%
Revenue Next 5 Year
415.19%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
11.13%
EBIT Next 5 Year
N/A

ATYR PHARMA INC / ATYR Forecast FAQ

What is the average price target for ATYR PHARMA INC (ATYR) stock?

16 analysts have analysed ATYR and the average price target is 6.48 USD. This implies a price increase of 671.11% is expected in the next year compared to the current price of 0.8409.

What is the next earnings date for ATYR stock?

ATYR PHARMA INC (ATYR) will report earnings on 2026-05-05.

Can you provide the consensus estimates for ATYR PHARMA INC next earnings?

The consensus EPS estimate for the next earnings of ATYR PHARMA INC (ATYR) is -0.15 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for ATYR stock?

The number of analysts covering ATYR PHARMA INC (ATYR) is 16.